메뉴 건너뛰기




Volumn 7, Issue 1, 2015, Pages

Long-term donepezil use for dementia with Lewy bodies: Results from an open-label extension of Phase III trial

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; DONEPEZIL; PLACEBO;

EID: 84925874293     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/s13195-014-0081-2     Document Type: Article
Times cited : (37)

References (33)
  • 1
    • 9144224226 scopus 로고    scopus 로고
    • International Psychogeriatric Association Expert Meeting on DLB: Dementia with Lewy bodies
    • McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, et al. International Psychogeriatric Association Expert Meeting on DLB: Dementia with Lewy bodies. Lancet Neurol. 2004;3:19-28.
    • (2004) Lancet Neurol , vol.3 , pp. 19-28
    • McKeith, I.1    Mintzer, J.2    Aarsland, D.3    Burn, D.4    Chiu, H.5    Cohen-Mansfield, J.6
  • 2
    • 0006164301 scopus 로고    scopus 로고
    • Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
    • 1:STN:280:DyaK2s%2FmsF2gtw%3D%3D 8909416
    • McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113-24.
    • (1996) Neurology , vol.47 , pp. 1113-1124
    • McKeith, I.G.1    Galasko, D.2    Kosaka, K.3    Perry, E.K.4    Dickson, D.W.5    Hansen, L.A.6
  • 3
    • 0035013468 scopus 로고    scopus 로고
    • The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease
    • 1:STN:280:DC%2BD3M3ps1GqtQ%3D%3D 11376466
    • Ballard C, O'Brien J, Morris CM, Barber R, Swann A, Neill D, et al. The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. Int J Geriatr Psychiatry. 2001;16:499-503.
    • (2001) Int J Geriatr Psychiatry , vol.16 , pp. 499-503
    • Ballard, C.1    O'Brien, J.2    Morris, C.M.3    Barber, R.4    Swann, A.5    Neill, D.6
  • 4
    • 0029880810 scopus 로고    scopus 로고
    • Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type
    • 1:STN:280:DyaK28zisVahsA%3D%3D 8670554
    • Ballard C, Patel A, Oyebode F, Wilcock G. Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type. Age Ageing. 1996;25:209-13.
    • (1996) Age Ageing , vol.25 , pp. 209-213
    • Ballard, C.1    Patel, A.2    Oyebode, F.3    Wilcock, G.4
  • 5
    • 0031722580 scopus 로고    scopus 로고
    • Cognitive decline is faster in Lewy body variant than in Alzheimer's disease
    • 1:STN:280:DyaK1czntlOktA%3D%3D 9710002
    • Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, et al. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology. 1998;51:351-7.
    • (1998) Neurology , vol.51 , pp. 351-357
    • Olichney, J.M.1    Galasko, D.2    Salmon, D.P.3    Hofstetter, C.R.4    Hansen, L.A.5    Katzman, R.6
  • 6
    • 84857858429 scopus 로고    scopus 로고
    • Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: A cohort study
    • Walker Z, McKeith I, Rodda J, Qassem T, Tatsch K, Booij J, et al. Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: a cohort study. BMJ Open. 2012;2:e000380.
    • (2012) BMJ Open , vol.2 , pp. 000380
    • Walker, Z.1    McKeith, I.2    Rodda, J.3    Qassem, T.4    Tatsch, K.5    Booij, J.6
  • 7
    • 0034456480 scopus 로고    scopus 로고
    • Fall-related injuries in dementia with Lewy bodies (DLB) and Alzheimer's disease
    • 1:STN:280:DC%2BD3c3ntVKjuw%3D%3D 10809918
    • Imamura T, Hirono N, Hashimoto M, Kazui H, Tanimukai S, Hanihara T, et al. Fall-related injuries in dementia with Lewy bodies (DLB) and Alzheimer's disease. Eur J Neurol. 2000;7:77-9.
    • (2000) Eur J Neurol , vol.7 , pp. 77-79
    • Imamura, T.1    Hirono, N.2    Hashimoto, M.3    Kazui, H.4    Tanimukai, S.5    Hanihara, T.6
  • 8
    • 58949095227 scopus 로고    scopus 로고
    • Risk factors for falls in community-dwelling patients with Alzheimer's disease and dementia with Lewy bodies: Walking with visuocognitive impairment may cause a fall
    • Kudo Y, Imamura T, Sato A, Endo N. Risk factors for falls in community-dwelling patients with Alzheimer's disease and dementia with Lewy bodies: walking with visuocognitive impairment may cause a fall. Dement Geriatr Cogn Disord. 2009;27:139-46.
    • (2009) Dement Geriatr Cogn Disord , vol.27 , pp. 139-146
    • Kudo, Y.1    Imamura, T.2    Sato, A.3    Endo, N.4
  • 9
    • 58349114729 scopus 로고    scopus 로고
    • Differences in clinical course between dementia with Lewy bodies and Alzheimer's disease
    • 1:STN:280:DC%2BD1M%2FnsVyisA%3D%3D 19146642
    • Hanyu H, Sato T, Hirao K, Kanetaka H, Sakurai H, Iwamoto T. Differences in clinical course between dementia with Lewy bodies and Alzheimer's disease. Eur J Neurol. 2009;16:212-7.
    • (2009) Eur J Neurol , vol.16 , pp. 212-217
    • Hanyu, H.1    Sato, T.2    Hirao, K.3    Kanetaka, H.4    Sakurai, H.5    Iwamoto, T.6
  • 10
    • 0035021618 scopus 로고    scopus 로고
    • The characterisation and impact of 'fluctuating' cognition in dementia with Lewy bodies and Alzheimer's disease
    • 1:STN:280:DC%2BD3M3ps1GqtA%3D%3D 11376465
    • Ballard C, Walker M, O'Brien J, Rowan E, McKeith I. The characterisation and impact of 'fluctuating' cognition in dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry. 2001;16:494-8.
    • (2001) Int J Geriatr Psychiatry , vol.16 , pp. 494-498
    • Ballard, C.1    Walker, M.2    O'Brien, J.3    Rowan, E.4    McKeith, I.5
  • 11
    • 34249939044 scopus 로고    scopus 로고
    • Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease
    • Boström F, Jönsson L, Minthon L, Londos E. Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease. Alzheimer Dis Assoc Disord. 2007;21:150-4.
    • (2007) Alzheimer Dis Assoc Disord , vol.21 , pp. 150-154
    • Boström, F.1    Jönsson, L.2    Minthon, L.3    Londos, E.4
  • 12
    • 84872086416 scopus 로고    scopus 로고
    • Examining carer stress in dementia: The role of subtype diagnosis and neuropsychiatric symptoms
    • Lee DR, McKeith I, Mosimann U, Ghosh-Nodyal A, Thomas AJ. Examining carer stress in dementia: the role of subtype diagnosis and neuropsychiatric symptoms. Int J Geriatr Psychiatry. 2013;28:135-41.
    • (2013) Int J Geriatr Psychiatry , vol.28 , pp. 135-141
    • Lee, D.R.1    McKeith, I.2    Mosimann, U.3    Ghosh-Nodyal, A.4    Thomas, A.J.5
  • 13
    • 33745813555 scopus 로고    scopus 로고
    • More severe functional impairment in dementia with lewy bodies than Alzheimer disease is related to extrapyramidal motor dysfunction
    • McKeith IG, Rowan E, Askew K, Naidu A, Allan L, Barnett N, et al. More severe functional impairment in dementia with lewy bodies than Alzheimer disease is related to extrapyramidal motor dysfunction. Am J Geriatr Psychiatry. 2006;14:582-8.
    • (2006) Am J Geriatr Psychiatry , vol.14 , pp. 582-588
    • McKeith, I.G.1    Rowan, E.2    Askew, K.3    Naidu, A.4    Allan, L.5    Barnett, N.6
  • 14
    • 0028279958 scopus 로고
    • Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease
    • 1:CAS:528:DyaK2cXkvVSitb4%3D 8018843
    • Perry EK, Haroutunian V, Davis KL, Levy R, Lantos P, Eagger S, et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport. 1994;5:747-9.
    • (1994) Neuroreport , vol.5 , pp. 747-749
    • Perry, E.K.1    Haroutunian, V.2    Davis, K.L.3    Levy, R.4    Lantos, P.5    Eagger, S.6
  • 15
    • 0027208615 scopus 로고
    • Cholinergic transmitter and neurotrophic activities in Lewy body dementia: Similarity to Parkinson's and distinction from Alzheimer disease
    • 1:STN:280:DyaK3szkvFCqtg%3D%3D 8347330
    • Perry EK, Irving D, Kerwin JM, McKeith IG, Thompson P, Collerton D, et al. Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease. Alzheimer Dis Assoc Disord. 1993;7:69-79.
    • (1993) Alzheimer Dis Assoc Disord , vol.7 , pp. 69-79
    • Perry, E.K.1    Irving, D.2    Kerwin, J.M.3    McKeith, I.G.4    Thompson, P.5    Collerton, D.6
  • 16
    • 34250213269 scopus 로고    scopus 로고
    • Efficacy and safety of galantamine in patients with dementia with Lewy bodies: A 24-week open-label study
    • 1:CAS:528:DC%2BD2sXmt1Sqsb8%3D 17409748
    • Edwards K, Royall D, Hershey L, Lichter D, Hake A, Farlow M, et al. Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study. Dement Geriatr Cogn Disord. 2007;23:401-5.
    • (2007) Dement Geriatr Cogn Disord , vol.23 , pp. 401-405
    • Edwards, K.1    Royall, D.2    Hershey, L.3    Lichter, D.4    Hake, A.5    Farlow, M.6
  • 17
    • 17844406874 scopus 로고    scopus 로고
    • Long-Term use of rivastigmine in patients with dementia with Lewy bodies: An open-label trial
    • 1:STN:280:DC%2BD3MvkvF2lug%3D%3D 11495394
    • Grace J, Daniel S, Stevens T, Shankar KK, Walker Z, Byrne EJ, et al. Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial. Int Psychogeriatr. 2001;13:199-205.
    • (2001) Int Psychogeriatr , vol.13 , pp. 199-205
    • Grace, J.1    Daniel, S.2    Stevens, T.3    Shankar, K.K.4    Walker, Z.5    Byrne, E.J.6
  • 18
    • 33644948649 scopus 로고    scopus 로고
    • Efficacy and safety of donepezil in patients with dementia with Lewy bodies: Preliminary findings from an open-label study
    • Mori S, Mori E, Iseki E, Kosaka K. Efficacy and safety of donepezil in patients with dementia with Lewy bodies: preliminary findings from an open-label study. Psychiatry Clin Neurosci. 2006;60:190-5.
    • (2006) Psychiatry Clin Neurosci , vol.60 , pp. 190-195
    • Mori, S.1    Mori, E.2    Iseki, E.3    Kosaka, K.4
  • 19
    • 33847354742 scopus 로고    scopus 로고
    • Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies
    • 1:CAS:528:DC%2BD2sXjsF2gt7g%3D 17192712
    • Rowan E, McKeith IG, Saxby BK, O'Brien JT, Burn D, Mosimann U, et al. Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies. Dement Geriatr Cogn Disord. 2007;23:161-7.
    • (2007) Dement Geriatr Cogn Disord , vol.23 , pp. 161-167
    • Rowan, E.1    McKeith, I.G.2    Saxby, B.K.3    O'Brien, J.T.4    Burn, D.5    Mosimann, U.6
  • 20
    • 30344485150 scopus 로고    scopus 로고
    • A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies
    • Thomas AJ, Burn DJ, Rowan EN, Littlewood E, Newby J, Cousins D, et al. A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies. Int J Geriatr Psychiatry. 2005;20:938-44.
    • (2005) Int J Geriatr Psychiatry , vol.20 , pp. 938-944
    • Thomas, A.J.1    Burn, D.J.2    Rowan, E.N.3    Littlewood, E.4    Newby, J.5    Cousins, D.6
  • 21
    • 0034676757 scopus 로고    scopus 로고
    • Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind, placebo-controlled international study
    • 1:CAS:528:DC%2BD3MXnvV2r 11145488
    • McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Anand R, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet. 2000;356:2031-6.
    • (2000) Lancet , vol.356 , pp. 2031-2036
    • McKeith, I.1    Del Ser, T.2    Spano, P.3    Emre, M.4    Wesnes, K.5    Anand, R.6
  • 22
    • 84864426175 scopus 로고    scopus 로고
    • Donepezil-DLB Study Investigators: Donepezil for dementia with Lewy bodies: A randomized, placebo-controlled trial
    • 1:CAS:528:DC%2BC38XhtVOgsLbF 22829268
    • Mori E, Ikeda M, Kosaka K. Donepezil-DLB Study Investigators: Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial. Ann Neurol. 2012;72:41-52.
    • (2012) Ann Neurol , vol.72 , pp. 41-52
    • Mori, E.1    Ikeda, M.2    Kosaka, K.3
  • 23
    • 84884680030 scopus 로고    scopus 로고
    • Donepezil-DLB Study Investigators: Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: Results from a 52-week, open-label, multicenter extension study
    • 1:CAS:528:DC%2BC3sXhsFelsLvK 23949147
    • Ikeda M, Mori E, Kosaka K, Iseki E, Hashimoto M, Matsukawa N, et al. Donepezil-DLB Study Investigators: Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: results from a 52-week, open-label, multicenter extension study. Dement Geriatr Cogn Disord. 2013;36:229-41.
    • (2013) Dement Geriatr Cogn Disord , vol.36 , pp. 229-241
    • Ikeda, M.1    Mori, E.2    Kosaka, K.3    Iseki, E.4    Hashimoto, M.5    Matsukawa, N.6
  • 24
    • 84925862152 scopus 로고    scopus 로고
    • Donepezil for dementia with Lewy bodies: A randomized placebo-controlled, confirmatory phase III trial
    • in press
    • Ikeda M, Mori E, Matsuo K, Nakagawa M, Kosaka K. Donepezil for dementia with Lewy bodies: a randomized placebo-controlled, confirmatory phase III trial. Alzheimers Res Ther. in press.
    • Alzheimers Res Ther
    • Ikeda, M.1    Mori, E.2    Matsuo, K.3    Nakagawa, M.4    Kosaka, K.5
  • 25
    • 0030958347 scopus 로고    scopus 로고
    • The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients
    • 1:STN:280:DyaK2s3pslKrtQ%3D%3D 9153155
    • Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology. 1997;48:S10-6.
    • (1997) Neurology , vol.48 , pp. 10-16
    • Cummings, J.L.1
  • 26
    • 0027985334 scopus 로고
    • The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
    • 1:STN:280:DyaK2M%2FotlWisw%3D%3D 7991117
    • Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308-14.
    • (1994) Neurology , vol.44 , pp. 2308-2314
    • Cummings, J.L.1    Mega, M.2    Gray, K.3    Rosenberg-Thompson, S.4    Carusi, D.A.5    Gornbein, J.6
  • 28
    • 0014082977 scopus 로고
    • Parkinsonism: Onset, progression and mortality
    • 1:STN:280:DyaF2s7jvFSgsg%3D%3D 6067254
    • Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427-42.
    • (1967) Neurology , vol.17 , pp. 427-442
    • Hoehn, M.M.1    Yahr, M.D.2
  • 29
    • 0016823810 scopus 로고
    • "mini-mental state. A practical method for grading the cognitive state of patients for the clinician
    • 1:STN:280:DyaE28%2FntFKjtw%3D%3D 1202204
    • Folstein MF, Folstein SE, McHugh PR. "Mini-mental state. a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-98.
    • (1975) J Psychiatr Res , vol.12 , pp. 189-198
    • Folstein, M.F.1    Folstein, S.E.2    McHugh, P.R.3
  • 30
    • 0019206831 scopus 로고
    • Relatives of the impaired elderly: Correlates of feelings of burden
    • 1:STN:280:DyaL3M7jvFOhtw%3D%3D 7203086
    • Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist. 1980;20:649-55.
    • (1980) Gerontologist , vol.20 , pp. 649-655
    • Zarit, S.H.1    Reever, K.E.2    Bach-Peterson, J.3
  • 31
    • 0000224448 scopus 로고
    • Unified Parkinson's disease rating scale
    • Fahn SER: UPDRS Development Committee (eds) 2 Macmillan Healthcare Information New York 293-304
    • Fahn SER: UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn SMC, Calne D, Goldstein M, editors. Recent developments in Parkinson's disease, vol. 2. New York: Macmillan Healthcare Information; 1987. p. 153-63. 293-304.
    • (1987) Recent Developments in Parkinson's Disease , pp. 153-163
    • Fahn, S.M.C.1    Calne, D.2    Goldstein, M.3
  • 32
    • 0008682024 scopus 로고    scopus 로고
    • Long-term safety and efficacy of acetylcholinesterase inhibitor E2020 in patients with Alzheimer-type dementia: 52-week open label study
    • Tohgi H, Homma A, Imai Y, Udaka F, Takeda M, Nishimura T, et al. Long-term safety and efficacy of acetylcholinesterase inhibitor E2020 in patients with Alzheimer-type dementia: 52-week open label study. Clin Eval. 2000;28:97-126.
    • (2000) Clin Eval , vol.28 , pp. 97-126
    • Tohgi, H.1    Homma, A.2    Imai, Y.3    Udaka, F.4    Takeda, M.5    Nishimura, T.6
  • 33
    • 60749113888 scopus 로고    scopus 로고
    • Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: Results from a 52-week, open-label, multicenter, extension study in Japan
    • 1:CAS:528:DC%2BD1MXivFyruro%3D 19246907
    • Homma A, Imai Y, Tago H, Asada T, Shigeta M, Iwamoto T, et al. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan. Dement Geriatr Cogn Disord. 2009;27:232-9.
    • (2009) Dement Geriatr Cogn Disord , vol.27 , pp. 232-239
    • Homma, A.1    Imai, Y.2    Tago, H.3    Asada, T.4    Shigeta, M.5    Iwamoto, T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.